Naratriptan USP Related Compound B

Forced degradation studies on Naratriptan HCL by high performance liquid chromatography
By Kulkarni, Vaibhav; Sonawane, Kiran
From International Electronic Conference on Synthetic Organic Chemistry, 21st, Nov. 1-30, 2017 (2017), 1-11
 
Validated stability indicating HPLC method for estimation of Naratriptan
By Lalitha, K. V.; Raveendra, Reddy J.; Devanna, N.
From International Research Journal of Pharmacy (2019), 10(11), 29-37
 
Development and validation of stability-​indicating HPTLC method for estimation of naratriptan hydrochloride in its pharmaceutical dosage form and its content uniformity testing
By Prajapati, Pintu B.; Chotalia, Jagdish; Bodiwala, Kunjan B.; Marolia, Bhavin P.; Shah, Shailesh A.
From Journal of Chromatographic Science (2016), 54(7), 1129-1136
 

Naratriptan USP Related Compound B is chemically 2-[3-(1-Methyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indol-5-yl]ethanesulfonic acid methylamide (as per USP). Naratriptan USP Related Compound B is supplied with detailed characterization data compliant with regulatory guideline. Naratriptan USP Related Compound B can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Naratriptan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.